Patent Application
Utility
PCT National Stage
App. No. 17/613,652
· Confirmation No. 1518
METHODS OF TREATING URINARY SYSTEM CANCERS
Inventors:
Riccardo Panicucci, Susan Arangio, Craig Berman, Michael Monteith, Harris Soifer, Gang Li, Carl Dambkowski, Daniel Mulreany
Applicant:
QED Therapeutics, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-01-27 | ABN |
Abandonment | 3 | View | |
| 2025-07-17 | CTFR |
Final Rejection | 30 | View | |
| 2025-07-17 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2025-07-17 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2025-04-08 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | — | View | |
| 2025-04-08 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-04-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2025-04-08 | DRW.NONBW |
Drawings-other than black and white line drawings | 7 | View | |
| 2025-04-08 | XT/ |
Extension of Time | 1 | View | |
| 2025-04-08 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2025-04-08 | SPEC |
Specification | 1 | View | |
| 2025-04-08 | REM |
Applicant Arguments/Remarks Made in an Amendment | 10 | View | |
| 2025-04-08 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2025-04-08 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2025-04-08 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2025-04-08 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2025-04-08 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2024-10-09 | CTNF |
Non-Final Rejection | 14 | View | |
| 2024-10-09 | 892 |
List of references cited by examiner | 1 | View | |
| 2024-10-09 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2024-10-09 | SRNT |
Examiner's search strategy and results | 3 | View | |
| 2024-10-09 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2024-10-09 | SRNT |
Examiner's search strategy and results | 3 | View | |
| 2024-10-09 | SRNT |
Examiner's search strategy and results | 10 | View | |
| 2024-10-09 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2022-08-23 | M903 |
Notice of Designated Office (DO) / Elected Office (EO) Acceptance Mailed | 2 | View | |
| 2022-08-23 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-08-16 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2022-08-16 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-08-16 | CLM |
Claims | 4 | View | |
| 2022-08-16 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-08-16 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-08-16 | N417 |
Electronic Filing System Acknowledgment Receipt | 5 | View | |
| 2022-08-16 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 15 | View | |
| 2022-08-16 | XT/ |
Extension of Time | 1 | View | |
| 2022-08-16 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2022-08-16 | FOR |
Foreign Reference | 3388 | View | |
| 2022-07-28 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-04-18 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2022-04-18 | 371.FEE.M923 |
371 (National Stage) Supplemental Fees Missing - Form M923 | 2 | View | |
| 2022-04-18 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-04-18 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-11-23 | DRW |
Drawings-only black and white line drawings | 6 | View | |
| 2021-11-23 | CLM |
Claims | 9 | View | |
| 2021-11-23 | SPEC |
Specification | 66 | View | |
| 2021-11-23 | FRPR |
Certified Copy of Foreign Priority Application | 94 | View | |
| 2021-11-23 | ABST |
Abstract | 1 | View | |
| 2021-11-23 | FRPR |
Certified Copy of Foreign Priority Application | 62 | View | |
| 2021-11-23 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 6 | View | |
| 2021-11-23 | 371P |
Documents submitted with 371 (National Stage) Applications | 1 | View | |
| 2021-11-23 | A.PE |
Preliminary Amendment | 1 | View | |
| 2021-11-23 | SPEC |
Specification | 1 | View | |
| 2021-11-23 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2021-11-23 | TRNA |
Transmittal of New Application | 3 | View | |
| 2021-11-23 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-11-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2021-11-23 | ADS |
Application Data Sheet | 11 | View |
Inventors
Riccardo Panicucci
Bluffton, SC
Susan Arangio
Los Altos, CA
Craig Berman
Mill Valley, CA
Michael Monteith
Raleigh, NC
Harris Soifer
San Diego, CA
Gang Li
San Diego, CA
Carl Dambkowski
San Mateo, CA
Daniel Mulreany
San Francisco, CA
Attorneys & Agents of Record
Classification
USPC
424/423
A61K31/506
C12Q1/6886
A61P35/00
G01N33/5759
A61K9/0024
A61K9/0034
A61K9/0053
A61K31/7068
A61M31/00
A61M2210/1085
C12Q1/6874
C12Q2600/106
C12Q2600/112
C12Q2600/156
C12Q2600/158
C12Q2600/16
G01N2333/70596
G01N2800/52
Prosecution
- Examiner
- PHAN, DOAN THI-THUC
- Art Unit
- 1613
- Customer No.
- 51414
- Docket No.
- QED-006WOUS
- Confirmation No.
- 1518
Publication
- Pub. No.
- US20220233537A1
- Pub. Date
- 2022-07-28
Parent
PCT
is a National Stage Entry of
→
PCT/US2020/035140
Filed 2020-05-29
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 62/906,194
Filed 2019-09-26
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/855,277
Filed 2019-05-31
· Provisional Application Expired
BRIDGEBIO PHARMA, INC.,
QED THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
CALCILYTIX THERAPEUTICS INC.,
ADRENAS THERAPEUTICS INC.,
PHOENIX TISSUE REPAIR, INC.,
NAVIRE PHARMA, INC.,
VENTHERA, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
PORTAL THERAPEUTICS, INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
FERRO THERAPEUTICS, INC.
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL
Recorded 2025-03-05
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
BRIDGEBIO PHARMA, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
QED THERAPEUTICS, INC.,
SUB21, INC.,
THERAS, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-19
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
SUB21, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/613,652
- Filed
- 2021-11-23
- Pub. No.
- US20220233537A1
- Examiner
- PHAN, DOAN THI-THUC
- Art Unit
- 1613
External Links